Global Drug Screening Equipments Market Research Report 2023
Global Drug Screening Equipments Market Overview:
Global Drug Screening Equipments Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Drug Screening Equipments involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Drug Screening Equipments Market
The Drug Screening Equipments Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Drug Screening Equipments Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Drug Screening Equipments Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Drug Screening Equipments Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Drug Screening Equipments market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Drug Screening Equipments Market Segmentation
Global Drug Screening Equipments Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Drug Screening Equipments market has been segmented into:
Immunoassay Analyzers
Chromatography Instruments
Breath Analyzers
Other
By Application, Drug Screening Equipments market has been segmented into:
Hospital
Biotechnology & Pharmaceutical Companies
Private Labs
Research Institute
Other
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Drug Screening Equipments market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Drug Screening Equipments market.
Top Key Players Covered in Drug Screening Equipments market are:
Alere
Express
Thermo Fisher
Roche
Shimadzu
Quest Diagnostics
Siemens
Mpd
Dr gerwerk
Objective to buy this Report:
1. Drug Screening Equipments analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Drug Screening Equipments market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Global Drug Screening Equipments Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Drug Screening Equipments involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Drug Screening Equipments Market
The Drug Screening Equipments Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Drug Screening Equipments Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Drug Screening Equipments Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Drug Screening Equipments Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Drug Screening Equipments market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Drug Screening Equipments Market Segmentation
Global Drug Screening Equipments Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Drug Screening Equipments market has been segmented into:
Immunoassay Analyzers
Chromatography Instruments
Breath Analyzers
Other
By Application, Drug Screening Equipments market has been segmented into:
Hospital
Biotechnology & Pharmaceutical Companies
Private Labs
Research Institute
Other
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Drug Screening Equipments market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Drug Screening Equipments market.
Top Key Players Covered in Drug Screening Equipments market are:
Alere
Express
Thermo Fisher
Roche
Shimadzu
Quest Diagnostics
Siemens
Mpd
Dr gerwerk
Objective to buy this Report:
1. Drug Screening Equipments analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Drug Screening Equipments market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
CHAPTER 1: INTRODUCTION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: DRUG SCREENING EQUIPMENTS MARKET BY TYPE
5.1 Drug Screening Equipments Market Overview Snapshot and Growth Engine
5.2 Drug Screening Equipments Market Overview
5.3 Immunoassay Analyzers
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Immunoassay Analyzers: Geographic Segmentation
5.4 Chromatography Instruments
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Chromatography Instruments: Geographic Segmentation
5.5 Breath Analyzers
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Breath Analyzers: Geographic Segmentation
5.6 Other
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2028F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Other: Geographic Segmentation
CHAPTER 6: DRUG SCREENING EQUIPMENTS MARKET BY APPLICATION
6.1 Drug Screening Equipments Market Overview Snapshot and Growth Engine
6.2 Drug Screening Equipments Market Overview
6.3 Hospital
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital: Geographic Segmentation
6.4 Biotechnology & Pharmaceutical Companies
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Biotechnology & Pharmaceutical Companies: Geographic Segmentation
6.5 Private Labs
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Private Labs: Geographic Segmentation
6.6 Research Institute
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2028F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Research Institute: Geographic Segmentation
6.7 Other
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2016-2028F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Other: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Drug Screening Equipments Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Drug Screening Equipments Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Drug Screening Equipments Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ALERE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 EXPRESS
7.4 THERMO FISHER
7.5 ROCHE
7.6 SHIMADZU
7.7 QUEST DIAGNOSTICS
7.8 SIEMENS
7.9 MPD
7.10 DR GERWERK
CHAPTER 8: GLOBAL DRUG SCREENING EQUIPMENTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Immunoassay Analyzers
8.2.2 Chromatography Instruments
8.2.3 Breath Analyzers
8.2.4 Other
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital
8.3.2 Biotechnology & Pharmaceutical Companies
8.3.3 Private Labs
8.3.4 Research Institute
8.3.5 Other
CHAPTER 9: NORTH AMERICA DRUG SCREENING EQUIPMENTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Immunoassay Analyzers
9.4.2 Chromatography Instruments
9.4.3 Breath Analyzers
9.4.4 Other
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital
9.5.2 Biotechnology & Pharmaceutical Companies
9.5.3 Private Labs
9.5.4 Research Institute
9.5.5 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE DRUG SCREENING EQUIPMENTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Immunoassay Analyzers
10.4.2 Chromatography Instruments
10.4.3 Breath Analyzers
10.4.4 Other
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital
10.5.2 Biotechnology & Pharmaceutical Companies
10.5.3 Private Labs
10.5.4 Research Institute
10.5.5 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC DRUG SCREENING EQUIPMENTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Immunoassay Analyzers
11.4.2 Chromatography Instruments
11.4.3 Breath Analyzers
11.4.4 Other
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital
11.5.2 Biotechnology & Pharmaceutical Companies
11.5.3 Private Labs
11.5.4 Research Institute
11.5.5 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA DRUG SCREENING EQUIPMENTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Immunoassay Analyzers
12.4.2 Chromatography Instruments
12.4.3 Breath Analyzers
12.4.4 Other
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital
12.5.2 Biotechnology & Pharmaceutical Companies
12.5.3 Private Labs
12.5.4 Research Institute
12.5.5 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA DRUG SCREENING EQUIPMENTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Immunoassay Analyzers
13.4.2 Chromatography Instruments
13.4.3 Breath Analyzers
13.4.4 Other
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital
13.5.2 Biotechnology & Pharmaceutical Companies
13.5.3 Private Labs
13.5.4 Research Institute
13.5.5 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: DRUG SCREENING EQUIPMENTS MARKET BY TYPE
5.1 Drug Screening Equipments Market Overview Snapshot and Growth Engine
5.2 Drug Screening Equipments Market Overview
5.3 Immunoassay Analyzers
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Immunoassay Analyzers: Geographic Segmentation
5.4 Chromatography Instruments
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Chromatography Instruments: Geographic Segmentation
5.5 Breath Analyzers
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Breath Analyzers: Geographic Segmentation
5.6 Other
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2028F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Other: Geographic Segmentation
CHAPTER 6: DRUG SCREENING EQUIPMENTS MARKET BY APPLICATION
6.1 Drug Screening Equipments Market Overview Snapshot and Growth Engine
6.2 Drug Screening Equipments Market Overview
6.3 Hospital
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital: Geographic Segmentation
6.4 Biotechnology & Pharmaceutical Companies
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Biotechnology & Pharmaceutical Companies: Geographic Segmentation
6.5 Private Labs
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Private Labs: Geographic Segmentation
6.6 Research Institute
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2028F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Research Institute: Geographic Segmentation
6.7 Other
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2016-2028F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Other: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Drug Screening Equipments Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Drug Screening Equipments Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Drug Screening Equipments Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ALERE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 EXPRESS
7.4 THERMO FISHER
7.5 ROCHE
7.6 SHIMADZU
7.7 QUEST DIAGNOSTICS
7.8 SIEMENS
7.9 MPD
7.10 DR GERWERK
CHAPTER 8: GLOBAL DRUG SCREENING EQUIPMENTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Immunoassay Analyzers
8.2.2 Chromatography Instruments
8.2.3 Breath Analyzers
8.2.4 Other
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital
8.3.2 Biotechnology & Pharmaceutical Companies
8.3.3 Private Labs
8.3.4 Research Institute
8.3.5 Other
CHAPTER 9: NORTH AMERICA DRUG SCREENING EQUIPMENTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Immunoassay Analyzers
9.4.2 Chromatography Instruments
9.4.3 Breath Analyzers
9.4.4 Other
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital
9.5.2 Biotechnology & Pharmaceutical Companies
9.5.3 Private Labs
9.5.4 Research Institute
9.5.5 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE DRUG SCREENING EQUIPMENTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Immunoassay Analyzers
10.4.2 Chromatography Instruments
10.4.3 Breath Analyzers
10.4.4 Other
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital
10.5.2 Biotechnology & Pharmaceutical Companies
10.5.3 Private Labs
10.5.4 Research Institute
10.5.5 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC DRUG SCREENING EQUIPMENTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Immunoassay Analyzers
11.4.2 Chromatography Instruments
11.4.3 Breath Analyzers
11.4.4 Other
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital
11.5.2 Biotechnology & Pharmaceutical Companies
11.5.3 Private Labs
11.5.4 Research Institute
11.5.5 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA DRUG SCREENING EQUIPMENTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Immunoassay Analyzers
12.4.2 Chromatography Instruments
12.4.3 Breath Analyzers
12.4.4 Other
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital
12.5.2 Biotechnology & Pharmaceutical Companies
12.5.3 Private Labs
12.5.4 Research Institute
12.5.5 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA DRUG SCREENING EQUIPMENTS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Immunoassay Analyzers
13.4.2 Chromatography Instruments
13.4.3 Breath Analyzers
13.4.4 Other
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital
13.5.2 Biotechnology & Pharmaceutical Companies
13.5.3 Private Labs
13.5.4 Research Institute
13.5.5 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. DRUG SCREENING EQUIPMENTS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. DRUG SCREENING EQUIPMENTS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. DRUG SCREENING EQUIPMENTS MARKET COMPETITIVE RIVALRY
TABLE 005. DRUG SCREENING EQUIPMENTS MARKET THREAT OF NEW ENTRANTS
TABLE 006. DRUG SCREENING EQUIPMENTS MARKET THREAT OF SUBSTITUTES
TABLE 007. DRUG SCREENING EQUIPMENTS MARKET BY TYPE
TABLE 008. IMMUNOASSAY ANALYZERS MARKET OVERVIEW (2016-2028)
TABLE 009. CHROMATOGRAPHY INSTRUMENTS MARKET OVERVIEW (2016-2028)
TABLE 010. BREATH ANALYZERS MARKET OVERVIEW (2016-2028)
TABLE 011. OTHER MARKET OVERVIEW (2016-2028)
TABLE 012. DRUG SCREENING EQUIPMENTS MARKET BY APPLICATION
TABLE 013. HOSPITAL MARKET OVERVIEW (2016-2028)
TABLE 014. BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET OVERVIEW (2016-2028)
TABLE 015. PRIVATE LABS MARKET OVERVIEW (2016-2028)
TABLE 016. RESEARCH INSTITUTE MARKET OVERVIEW (2016-2028)
TABLE 017. OTHER MARKET OVERVIEW (2016-2028)
TABLE 018. NORTH AMERICA DRUG SCREENING EQUIPMENTS MARKET, BY TYPE (2016-2028)
TABLE 019. NORTH AMERICA DRUG SCREENING EQUIPMENTS MARKET, BY APPLICATION (2016-2028)
TABLE 020. N DRUG SCREENING EQUIPMENTS MARKET, BY COUNTRY (2016-2028)
TABLE 021. EUROPE DRUG SCREENING EQUIPMENTS MARKET, BY TYPE (2016-2028)
TABLE 022. EUROPE DRUG SCREENING EQUIPMENTS MARKET, BY APPLICATION (2016-2028)
TABLE 023. DRUG SCREENING EQUIPMENTS MARKET, BY COUNTRY (2016-2028)
TABLE 024. ASIA PACIFIC DRUG SCREENING EQUIPMENTS MARKET, BY TYPE (2016-2028)
TABLE 025. ASIA PACIFIC DRUG SCREENING EQUIPMENTS MARKET, BY APPLICATION (2016-2028)
TABLE 026. DRUG SCREENING EQUIPMENTS MARKET, BY COUNTRY (2016-2028)
TABLE 027. MIDDLE EAST & AFRICA DRUG SCREENING EQUIPMENTS MARKET, BY TYPE (2016-2028)
TABLE 028. MIDDLE EAST & AFRICA DRUG SCREENING EQUIPMENTS MARKET, BY APPLICATION (2016-2028)
TABLE 029. DRUG SCREENING EQUIPMENTS MARKET, BY COUNTRY (2016-2028)
TABLE 030. SOUTH AMERICA DRUG SCREENING EQUIPMENTS MARKET, BY TYPE (2016-2028)
TABLE 031. SOUTH AMERICA DRUG SCREENING EQUIPMENTS MARKET, BY APPLICATION (2016-2028)
TABLE 032. DRUG SCREENING EQUIPMENTS MARKET, BY COUNTRY (2016-2028)
TABLE 033. ALERE: SNAPSHOT
TABLE 034. ALERE: BUSINESS PERFORMANCE
TABLE 035. ALERE: PRODUCT PORTFOLIO
TABLE 036. ALERE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 036. EXPRESS: SNAPSHOT
TABLE 037. EXPRESS: BUSINESS PERFORMANCE
TABLE 038. EXPRESS: PRODUCT PORTFOLIO
TABLE 039. EXPRESS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 039. THERMO FISHER: SNAPSHOT
TABLE 040. THERMO FISHER: BUSINESS PERFORMANCE
TABLE 041. THERMO FISHER: PRODUCT PORTFOLIO
TABLE 042. THERMO FISHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 042. ROCHE: SNAPSHOT
TABLE 043. ROCHE: BUSINESS PERFORMANCE
TABLE 044. ROCHE: PRODUCT PORTFOLIO
TABLE 045. ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. SHIMADZU: SNAPSHOT
TABLE 046. SHIMADZU: BUSINESS PERFORMANCE
TABLE 047. SHIMADZU: PRODUCT PORTFOLIO
TABLE 048. SHIMADZU: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. QUEST DIAGNOSTICS: SNAPSHOT
TABLE 049. QUEST DIAGNOSTICS: BUSINESS PERFORMANCE
TABLE 050. QUEST DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 051. QUEST DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. SIEMENS: SNAPSHOT
TABLE 052. SIEMENS: BUSINESS PERFORMANCE
TABLE 053. SIEMENS: PRODUCT PORTFOLIO
TABLE 054. SIEMENS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. MPD: SNAPSHOT
TABLE 055. MPD: BUSINESS PERFORMANCE
TABLE 056. MPD: PRODUCT PORTFOLIO
TABLE 057. MPD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. DR GERWERK: SNAPSHOT
TABLE 058. DR GERWERK: BUSINESS PERFORMANCE
TABLE 059. DR GERWERK: PRODUCT PORTFOLIO
TABLE 060. DR GERWERK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. DRUG SCREENING EQUIPMENTS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. DRUG SCREENING EQUIPMENTS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. DRUG SCREENING EQUIPMENTS MARKET COMPETITIVE RIVALRY
TABLE 005. DRUG SCREENING EQUIPMENTS MARKET THREAT OF NEW ENTRANTS
TABLE 006. DRUG SCREENING EQUIPMENTS MARKET THREAT OF SUBSTITUTES
TABLE 007. DRUG SCREENING EQUIPMENTS MARKET BY TYPE
TABLE 008. IMMUNOASSAY ANALYZERS MARKET OVERVIEW (2016-2028)
TABLE 009. CHROMATOGRAPHY INSTRUMENTS MARKET OVERVIEW (2016-2028)
TABLE 010. BREATH ANALYZERS MARKET OVERVIEW (2016-2028)
TABLE 011. OTHER MARKET OVERVIEW (2016-2028)
TABLE 012. DRUG SCREENING EQUIPMENTS MARKET BY APPLICATION
TABLE 013. HOSPITAL MARKET OVERVIEW (2016-2028)
TABLE 014. BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET OVERVIEW (2016-2028)
TABLE 015. PRIVATE LABS MARKET OVERVIEW (2016-2028)
TABLE 016. RESEARCH INSTITUTE MARKET OVERVIEW (2016-2028)
TABLE 017. OTHER MARKET OVERVIEW (2016-2028)
TABLE 018. NORTH AMERICA DRUG SCREENING EQUIPMENTS MARKET, BY TYPE (2016-2028)
TABLE 019. NORTH AMERICA DRUG SCREENING EQUIPMENTS MARKET, BY APPLICATION (2016-2028)
TABLE 020. N DRUG SCREENING EQUIPMENTS MARKET, BY COUNTRY (2016-2028)
TABLE 021. EUROPE DRUG SCREENING EQUIPMENTS MARKET, BY TYPE (2016-2028)
TABLE 022. EUROPE DRUG SCREENING EQUIPMENTS MARKET, BY APPLICATION (2016-2028)
TABLE 023. DRUG SCREENING EQUIPMENTS MARKET, BY COUNTRY (2016-2028)
TABLE 024. ASIA PACIFIC DRUG SCREENING EQUIPMENTS MARKET, BY TYPE (2016-2028)
TABLE 025. ASIA PACIFIC DRUG SCREENING EQUIPMENTS MARKET, BY APPLICATION (2016-2028)
TABLE 026. DRUG SCREENING EQUIPMENTS MARKET, BY COUNTRY (2016-2028)
TABLE 027. MIDDLE EAST & AFRICA DRUG SCREENING EQUIPMENTS MARKET, BY TYPE (2016-2028)
TABLE 028. MIDDLE EAST & AFRICA DRUG SCREENING EQUIPMENTS MARKET, BY APPLICATION (2016-2028)
TABLE 029. DRUG SCREENING EQUIPMENTS MARKET, BY COUNTRY (2016-2028)
TABLE 030. SOUTH AMERICA DRUG SCREENING EQUIPMENTS MARKET, BY TYPE (2016-2028)
TABLE 031. SOUTH AMERICA DRUG SCREENING EQUIPMENTS MARKET, BY APPLICATION (2016-2028)
TABLE 032. DRUG SCREENING EQUIPMENTS MARKET, BY COUNTRY (2016-2028)
TABLE 033. ALERE: SNAPSHOT
TABLE 034. ALERE: BUSINESS PERFORMANCE
TABLE 035. ALERE: PRODUCT PORTFOLIO
TABLE 036. ALERE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 036. EXPRESS: SNAPSHOT
TABLE 037. EXPRESS: BUSINESS PERFORMANCE
TABLE 038. EXPRESS: PRODUCT PORTFOLIO
TABLE 039. EXPRESS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 039. THERMO FISHER: SNAPSHOT
TABLE 040. THERMO FISHER: BUSINESS PERFORMANCE
TABLE 041. THERMO FISHER: PRODUCT PORTFOLIO
TABLE 042. THERMO FISHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 042. ROCHE: SNAPSHOT
TABLE 043. ROCHE: BUSINESS PERFORMANCE
TABLE 044. ROCHE: PRODUCT PORTFOLIO
TABLE 045. ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. SHIMADZU: SNAPSHOT
TABLE 046. SHIMADZU: BUSINESS PERFORMANCE
TABLE 047. SHIMADZU: PRODUCT PORTFOLIO
TABLE 048. SHIMADZU: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. QUEST DIAGNOSTICS: SNAPSHOT
TABLE 049. QUEST DIAGNOSTICS: BUSINESS PERFORMANCE
TABLE 050. QUEST DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 051. QUEST DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. SIEMENS: SNAPSHOT
TABLE 052. SIEMENS: BUSINESS PERFORMANCE
TABLE 053. SIEMENS: PRODUCT PORTFOLIO
TABLE 054. SIEMENS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. MPD: SNAPSHOT
TABLE 055. MPD: BUSINESS PERFORMANCE
TABLE 056. MPD: PRODUCT PORTFOLIO
TABLE 057. MPD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. DR GERWERK: SNAPSHOT
TABLE 058. DR GERWERK: BUSINESS PERFORMANCE
TABLE 059. DR GERWERK: PRODUCT PORTFOLIO
TABLE 060. DR GERWERK: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY TYPE
FIGURE 012. IMMUNOASSAY ANALYZERS MARKET OVERVIEW (2016-2028)
FIGURE 013. CHROMATOGRAPHY INSTRUMENTS MARKET OVERVIEW (2016-2028)
FIGURE 014. BREATH ANALYZERS MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHER MARKET OVERVIEW (2016-2028)
FIGURE 016. DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY APPLICATION
FIGURE 017. HOSPITAL MARKET OVERVIEW (2016-2028)
FIGURE 018. BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET OVERVIEW (2016-2028)
FIGURE 019. PRIVATE LABS MARKET OVERVIEW (2016-2028)
FIGURE 020. RESEARCH INSTITUTE MARKET OVERVIEW (2016-2028)
FIGURE 021. OTHER MARKET OVERVIEW (2016-2028)
FIGURE 022. NORTH AMERICA DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. EUROPE DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. ASIA PACIFIC DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. MIDDLE EAST & AFRICA DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. SOUTH AMERICA DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY TYPE
FIGURE 012. IMMUNOASSAY ANALYZERS MARKET OVERVIEW (2016-2028)
FIGURE 013. CHROMATOGRAPHY INSTRUMENTS MARKET OVERVIEW (2016-2028)
FIGURE 014. BREATH ANALYZERS MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHER MARKET OVERVIEW (2016-2028)
FIGURE 016. DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY APPLICATION
FIGURE 017. HOSPITAL MARKET OVERVIEW (2016-2028)
FIGURE 018. BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET OVERVIEW (2016-2028)
FIGURE 019. PRIVATE LABS MARKET OVERVIEW (2016-2028)
FIGURE 020. RESEARCH INSTITUTE MARKET OVERVIEW (2016-2028)
FIGURE 021. OTHER MARKET OVERVIEW (2016-2028)
FIGURE 022. NORTH AMERICA DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. EUROPE DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. ASIA PACIFIC DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. MIDDLE EAST & AFRICA DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. SOUTH AMERICA DRUG SCREENING EQUIPMENTS MARKET OVERVIEW BY COUNTRY (2016-2028)